Rythm, Inc.

Tobacco • Consumer Defensive • Troy, MI, United States • RYM (NCM)

855 420 0020 2468 Industrial Row Dr., Troy, MI 48084, United States

Quarter: Q2 2025 Reported: June 13, 2025 Sentiment: Neutral

RYTHM, Inc. provides solutions for the cannabis and hemp industry in the United States. It offers consumers hemp-derived tetrahydrocannabinol beverages under the Señorita brand name. The company was formerly known as Agrify Corporation and changed its name to Agrify Corporation RYTHM, Inc. in August 2025. RYTHM, Inc. was incorporated in 2016 and is headquartered in Troy, Michigan.

Analysis Summary

This document is a Form 8-K filing for Agrify Corporation (AGFY) detailing the outcomes of its 2025 Annual Meeting of Stockholders held on June 11, 2025, not an earnings call transcript for RYTHM, Inc. (RYM). As such, it does not contain any financial performance data, revenue, earnings, or forward guidance. The analysis below is based solely on the corporate governance information provided for Agrify Corporation.

**Annual Meeting Outcomes:**
Agrify Corporation successfully conducted its 2025 Annual Meeting of Stockholders virtually, achieving a robust quorum with 1,406,225 shares (approximately 72.0%) of the 1,952,014 eligible shares represented. All three proposals presented to shareholders were approved.

**Director Elections:**
Seven director nominees — Benjamin Kovler, Max Holtzman, Timothy Mahoney, Peter S. Shapiro, Sanjay Tolia, Armon Vakili, and Krishnan Varier — were elected for a one-year term expiring at the 2026 annual meeting. The election results showed strong support for the nominees, with 'Votes For' significantly outweighing 'Votes Withheld' for each candidate, indicating shareholder confidence in the current board structure.

**Auditor Ratification:**
The appointment of GuzmanGray as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was overwhelmingly ratified by shareholders, with 1,390,109 votes for and only 578 against, demonstrating strong shareholder alignment on financial oversight.

**Equity Incentive Plan Amendment:**
Shareholders approved an amendment to the 2022 Omnibus Equity Incentive Plan, increasing the number of shares available for issuance by 250,000. This approval, with 1,015,173 votes for, suggests shareholder support for the company's strategy to attract, retain, and incentivize employees and directors through equity compensation. This move is a common practice to align employee interests with shareholder value but also represents potential dilution.

**Management Commentary and Forward Guidance:**
No management commentary on business performance or forward guidance was provided in this Form 8-K, as its scope is limited to the annual meeting's voting results.

**Competitive Positioning and Market Trends:**
This document does not offer insights into competitive positioning or market trends.

**Risk Factors and Concerns:**
No specific risk factors or concerns regarding the company's operations or financial health were raised or discussed in this governance-focused filing. The approval of the equity plan amendment, while beneficial for incentives, inherently carries a risk of share dilution for existing shareholders, though this was not highlighted as a concern within the document itself.

**Analyst Q&A Highlights:**
No analyst Q&A session occurred or was reported in this Form 8-K.

Key Highlights

• All seven director nominees were elected for a one-year term.
• GuzmanGray was ratified as the independent registered public accounting firm for fiscal year 2025.
• Shareholders approved an amendment to the 2022 Omnibus Equity Incentive Plan.
• The equity plan amendment increases available shares for issuance by 250,000.
• A strong quorum of 72.0% of eligible shares was represented at the Annual Meeting.
• The document is a Form 8-K for Agrify Corporation (AGFY), not an earnings call for RYTHM, Inc. (RYM).

Financial Metrics

eps

YoY: N/A

revenue

N/A

YoY: N/A

guidance

net income

N/A

YoY: N/A

Stock Performance (90 Days)

Data through May 15, 2026

Positive Signals

• High shareholder participation with a 72.0% quorum.
• Unanimous approval of all director nominees.
• Overwhelming ratification of the independent auditor.
• Shareholder approval of the equity incentive plan amendment, indicating support for compensation strategy.

Risks & Concerns

— No specific operational or financial risk factors were discussed in this governance-focused Form 8-K.
— Potential for future share dilution due to the increase in shares available under the equity incentive plan (inherent, but not explicitly stated as a risk in the document).